Most Active Stocks
Last Post: 10/29/2025 9:32:16 AM
Board Marks: 17
Posts Today: 0
Board Views Today: 207
Post
Subject
Author
Posted On
Recent Articles
- DXS International's Annual Report: Key Insights and Financials
- Digitalist Group's Third Quarter Review Highlights 2025 Results
- Strong Q3 Results Highlight Growth and Stability for WEHB
- NB Private Equity Partners Effectively Executes Share Buyback
- ICG Enterprise Trust plc Makes Strategic Share Buyback Move
- Understanding the Voting Rights of Northern Venture Trust PLC
- Nanobiotix Partners with Healthcare Royalty for $71 Million Deal
- Fresnillo Enters Agreement to Purchase Probe Gold for C$780M
- Understanding Voting Rights at Northern 2 VCT PLC
- Notable Growth for INVL Technology in 2025 Financials
- Understanding the Latest Net Asset Value of INVL Technology
- Nxera Pharma's Vision Unveiled at Upcoming London Healthcare Conference
- Bioretec Ltd Adjusts H1 Report: Financial Highlights and Outlook
- Tetragon Financial Group Reveals September 2025 Insights
- Bioretec Ltd Updates Financial Report Details for 2025
- Loomis Reports Robust Performance in Q3 2025 with Growth
- Investments from Optiver and Qube Strengthen McKay Brothers
- Strategic Investments by Optiver and QRT Propel McKay Brothers
- Mycenax Partners with RIN Institute to Transform ADC Technology
- Transforming Enterprises: FastGPT's No-code AI Solutions for 2025
- Corbus Pharmaceuticals Moves Forward with Public Offering
- S&P 500 Achieves Historic Winning Streak and Market Insights
- Key Challenges Highlighted by Michael Saylor for Growth Strategy
- Ecer.com Launches Innovative AI Marketplace Strategy for Trade
- Bioretec Ltd Revises 2025 Half-Year Report with Key Updates
- DigitalXForce Achieves Prestigious Leader Status in IDC Assessment
- Danske Bank Sees Positive Trends and Growth for 2025
- Sampo plc's Latest Share Buyback Program and Results
- Exciting Developments in Kudu Well Appraisal by BW Energy
- Aalberts N.V. Strengthens Position with GVT Acquisition
- Nxera Pharma's Innovations and Financial Report for 2025
- Nxera Pharma Expands Manufacturing to Meet Growing Demand for QUVIVIQ®
- Vistin Pharma Reports Strong Q3 Results and Market Growth
- Corbus Pharmaceuticals Sets Price for New Stock Offering
- Introducing a New Executive Team Member at Realkredit Danmark
- Aalberts Enhances Market Position Through Latest Acquisition
- Exploring the Future of Green Hydrogen Development
- Aker Solutions ASA Sees Revenue Boost in Third Quarter
- Aker Solutions Reports Strong Performance in Q3 2025
- Aker Solutions’ Record Growth and Promising Future Outlook
- Investigation Launched into Conduent's Major Data Breach Event
- Vallourec Secures Groundbreaking Contract for Deepwater Project
- Essential Patient Inquiries for Portable X-Ray Scheduling
- Exploring Affordable Coastal Living Alternatives Near Beaches
- Intensity Therapeutics Sees Dip After Surging to New Heights
- Marimekko's Strategic Growth and Operations in 2025
- SCOR Reports Impressive Q3 2025 Earnings and Growth Metrics
- SPIE Reports Robust Growth and Strategic Acquisitions in 2025
- Trifork Group Achieves 4.7% Revenue Growth in Q3 Growth Report
- Ekspress Grupp’s Revenue Growth and Future Strategies Unveiled